Intra-Cellular Therapies, Inc. Annual Earnings Per Share, Basic in USD/shares from 2020 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Intra-Cellular Therapies, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2020 to 2023.
  • Intra-Cellular Therapies, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.25 USD/shares, unchanged year-over-year.
  • Intra-Cellular Therapies, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -0.87 USD/shares, a 46% increase year-over-year.
  • Intra-Cellular Therapies, Inc. annual Earnings Per Share, Basic for 2023 was -1.46 USD/shares, a 46.3% increase from 2022.
  • Intra-Cellular Therapies, Inc. annual Earnings Per Share, Basic for 2022 was -2.72 USD/shares, a 22.3% increase from 2021.
  • Intra-Cellular Therapies, Inc. annual Earnings Per Share, Basic for 2021 was -3.5 USD/shares, a 8.36% decline from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$1 +$1.26 +46.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-22
2022 -$3 +$0.78 +22.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
2021 -$4 $0 -8.36% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-22
2020 -$3 Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.